Navigation Links
The Board of Directors of Kinex Pharmaceuticals Appoints Dr. David Hangauer as Chief Scientific Officer
Date:5/17/2011

BUFFALO, N.Y., May 17, 2011 /PRNewswire/ -- Kinex Pharmaceuticals, LLC announced today that Dr. David Hangauer, who served as the Founding Senior Vice President of Research, will be appointed as Chief Scientific Officer of the Company.  

Dr. Johnson Lau, Chairman and Chief Executive Officer, stated, "David discovered and designed both of our lead compounds, KX01 and KX02. He is the soul of our scientific discovery programs. I have worked together with him for the last 7 years and he is always at his best, both scientifically and from his managing of the scientific team. I am honored that he has accepted the Chief Scientific Officer position and I look forward to working with him to grow Kinex Pharmaceuticals from a scientific perspective."

Dr. Hangauer is a leader in the field of medicinal chemistry.  Following doctoral studies in chemistry at The University at Buffalo, he spent nine years at Merck Sharp and Dohme Research Laboratories where he directed a variety of drug discovery projects and, in addition, was an early pioneer in the area of structure-based drug design.  In 1989, he returned to academia and joined the chemistry faculty at The University at Buffalo where he has had a productive research career that focused initially on developing a new approach to the design of protein kinase inhibitors which led to Mimetica™, the patented technology Kinex Pharmaceuticals licensed from The University at Buffalo and upon which the company was originally based.

Dr. Hangauer's academic research is focused on the energetics of drugs binding to their receptors and has published extensively in this area. He has taught a range of courses to graduate and undergraduate students in medicinal and organic chemistry.  

Dr. Hangauer's expertise has been sought by pharmaceutical and biotechnology companies worldwide, including Lederle /Wyeth-Ayerst Research Laboratories, New Medical Technologies, Sphinx/Eli Lilly Pharmaceut
'/>"/>

SOURCE Kinex Pharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inhibikase Therapeutics Elects Steven C. Gilman, Ph.D., to Board of Directors
2. HYCOR Expands Board of Directors to Support Growth in Key Areas
3. Instacare Corp. Board of Directors Considers Recent Merger Proposal Inadequate
4. The Board of Directors of Kinex Pharmaceuticals Appoints Dr. Allen Barnett as President Emeritus and Dr. Johnson Lau as Chief Executive Officer
5. TriReme Medical Lines Up Asian Strategy With Key Appointment of New Board Members
6. Qforma Appoints New Member to Board of Directors
7. Abaxis Appoints Vernon Altman to Board of Directors
8. TeleTrackings Patient Flow Dashboard XT™ Stops Operational Problems Before They Start
9. Hospira Board Authorizes $1 Billion Share Repurchase Program
10. Thomas Mac Mahon Joins SynapDx Corporations Board of Directors
11. Valeant Pharmaceuticals Responds to Cephalon Boards Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 1, 2014 Ardelyx, Inc. (NASDAQ: ... company focused on cardio-renal, gastrointestinal and metabolic ... 371 patient Phase 2b clinical trial evaluating ... syndrome (IBS-C).  Results from this study demonstrated ... IBS-C symptoms for tenapanor-treated patients compared to ...
(Date:10/1/2014)... , Switzerland , October 1, ... leader in Clinical Genomics and Next Generation Sequencing (NGS) ... allowing clinicians to run full cystic fibrosis analysis in ... the identification and characterisation of all types of variants ... performance. Until now, it has not been ...
(Date:9/30/2014)... 30, 2014  Wrightington, Wigan ... MDRX ) are delighted to announce WWL,s ... new health information system. The system will be implemented ... the way WWL delivers healthcare in the future. ... record of on-time and on-budget system implementations as well ...
Breaking Medicine Technology:Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 2Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 5Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 6Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment 2Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 2Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 3Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 4
... Calif., Feb. 16, 2012  Questcor Pharmaceuticals, Inc. (NASDAQ: ... of Scott M. Whitcup, M.D., 52, to its ... Vice President, Research & Development and Chief Scientific ... is responsible for leading Allergan,s global research and ...
...   ,The 28th Korea International Medical & Hospital Facility Exhibition(KIMES ... is held at COEX, SEOUL, from Feb.1619. ... national keep-fit, development of medical scholarship and ... Korea E&EX, KMDICA(Korea Medical Devices Industrial Cooperative ...
Cached Medicine Technology:Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors 2Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors 3Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors 4To Take a Glance Cutting Edge Medicine Equipment! 'The 28th International Medical & Hospital Equipment Show' 2To Take a Glance Cutting Edge Medicine Equipment! 'The 28th International Medical & Hospital Equipment Show' 3
(Date:10/1/2014)... Patients with increased inflammation, including those receiving ... risk of depression. For example, a 6-month treatment ... virus infection causes depression in approximately 30% of ... known as fish oil, have a long list ... heart disease and reducing triglyceride levels. These nutritional ...
(Date:10/1/2014)... people to keep their "eyes on the prize" may ... walking, staying focused on a specific target ahead can ... people walk there faster, psychology researchers have found. Their ... around the environment naturally, offers a new strategy to ... interested in exercise if physical activity seems daunting, which ...
(Date:10/1/2014)... Marriagelifeinsurance.com has released a new blog post explaining how ... Senior citizens can purchase a joint life insurance policy ... joint policy is cheaper, but will only pay benefits ... insurance can be used to cover important funeral expenses. ... as the application process is simple and straightforward. ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Bedros Keuilian ... Body Boot Camp fitness boot camps, he’s also considered ... training , with sold out business summits, a line ... marketing consultant to a recent Spike TV reality show ... that now is the time for personal trainers and ...
(Date:10/1/2014)... Reno, Nev. (PRWEB) October 01, 2014 ... through measuring abnormal circadian cellular changes throughout the body, ... Health, Inc. to better address the company’s breadth of ... wearable early breast cancer screening technology. , “Our initial ... breast cancer system which detects abnormal circadian cellular changes ...
Breaking Medicine News(10 mins):Health News:Omega-3 fatty acids may prevent some forms of depression 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 3Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 4
... it possible to build supercomputers that can replicate the ... to an implantable chip for interfacing with neurons and ... nanoscience and neuroscience are now advancing each other in ... what this means was the topic of an hour-long ...
... ... ... ... ...
... ... ... ... ...
... the work-weary, the word "vacation" may conjure images of ... But according to published research by a University of ... one of the fastest growing markets in vacation travel ... and into the realm of personal enrichment and fulfillment. ...
... ... February 28th, issued an email entitled "Fear Not!" , ... Pensacola, FL (PRWEB) March 4, 2010 -- ... issued an email entitled "Fear Not!" "We received a message from one of our ...
... , ... ... ... ...
Cached Medicine News:Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 2Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 3Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 4Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 5Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 6Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 7Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 8Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 9Health News:The SCOOTER Store Announces Coast-to-Coast Expansion of Local Stores 2Health News:The SCOOTER Store Announces Coast-to-Coast Expansion of Local Stores 3Health News:The SCOOTER Store Announces Coast-to-Coast Expansion of Local Stores 4Health News:Genealogical tourism redefining leisure travel market, professor says 2Health News:Genealogical tourism redefining leisure travel market, professor says 3Health News:The Power of Prayer Deterred Tsunami's Destruction Ministry Reports 2Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 2Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 3Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 4Health News:New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid 5
... External Fixator provides a stable ... diameter K wires (0.8 ... hold is utilized to construct ... and positions intervening joints in ...
The Medium External Fixator has a double-rod frame, medium Combination Clamp medium Multi-Pin Clamp, and Carbon Fiber Rods. Rod Attachment for Medium Multi-Pin Clamp allows second rod to be added....
... No need to add individual components for ... of trauma indications. Made of an innovative ... conventional fixators, only much lighter. This means ... and more comfortable for the patient. ,Comes ...
... injectable low osmolar, nonionic, contrast media ... biologically inert when injected intra-arterially. Each ... of ioversol, 3.6 mg of tromethamine ... of edetate calcium disodium as a ...
Medicine Products: